Cargando…

Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report

Detalles Bibliográficos
Autores principales:	Kudo, Ko, Kubota, Yasuo, Toki, Tsutomu, Kanezaki, Rika, Kobayashi, Akie, Sato, Tomohiko, Kamio, Takuya, Sasaki, Shinya, Shiba, Norio, Tomizawa, Daisuke, Adachi, Souichi, Yoshida, Kenichi, Ogawa, Seishi, Seki, Masafumi, Takita, Junko, Ito, Etsuro, Terui, Kiminori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131903/ https://www.ncbi.nlm.nih.gov/pubmed/35139176 http://dx.doi.org/10.1182/bloodadvances.2021006383

Ejemplares similares

Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome–related myeloid disorders
por: Kanezaki, Rika, et al.
Publicado: (2022)

Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond‐Blackfan anaemia
por: Kobayashi, Akie, et al.
Publicado: (2022)

Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype
por: Hiwatari, Mitsuteru, et al.
Publicado: (2017)

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
por: Kudo, Ko, et al.
Publicado: (2022)

Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome
por: Kubota, Yasuo, et al.
Publicado: (2019)

A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1
por: Korff, Ane, et al.
Publicado: (2023)

P527: DISTINCTIVE CLONAL EVOLUTION PATTERN AND PROGNOSTIC SIGNIFICANCE OF THE CLONALITY OF KRAS MUTATIONS IN KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
por: Matsuo, Hidemasa, et al.
Publicado: (2023)

Kudo K, Kubota Y, Toki T, et al. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report. Blood Adv. 2022;6(10):3162-3166.
Publicado: (2022)

HNRNPH1 is required for rhabdomyosarcoma cell growth and survival
por: Li, Yanfeng, et al.
Publicado: (2018)

Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity
por: Yazdani, Neema, et al.
Publicado: (2015)

Rett-like Phenotypes in HNRNPH2-Related Neurodevelopmental Disorder
por: Gonzalez, Joseph Nicho, et al.
Publicado: (2023)

Discovery of an MLLT1/3 YEATS Domain Chemical Probe
por: Moustakim, Moses, et al.
Publicado: (2018)

Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
por: LeFave, Clare V, et al.
Publicado: (2011)

Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome
por: Yamato, Genki, et al.
Publicado: (2021)

Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017)

Distinct roles of hnRNPH1 low-complexity domains in splicing and transcription
por: Kim, Ga Hye, et al.
Publicado: (2021)

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia
por: Kaburagi, Taeko, et al.
Publicado: (2021)

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
por: Tomizawa, Daisuke, et al.
Publicado: (2013)

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL
por: Kang, Huining, et al.
Publicado: (2018)

Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers
por: Walsh, Kyle M, et al.
Publicado: (2022)

Global Profiling of Alternative Splicing Events and Gene Expression Regulated by hnRNPH/F
por: Wang, Erming, et al.
Publicado: (2012)

Detailed Clinical and Psychological Phenotype of the X-linked HNRNPH2-Related Neurodevelopmental Disorder
por: Bain, Jennifer M., et al.
Publicado: (2021)

MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours
por: Perlman, Elizabeth J., et al.
Publicado: (2015)

The Association of the Copy Number Variation of the MLLT10 Gene with Growth Traits of Chinese Cattle
por: Yang, Peng, et al.
Publicado: (2020)

MLLT6 maintains PD‐L1 expression and mediates tumor immune resistance
por: Sreevalsan, Sandeep, et al.
Publicado: (2020)

Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development
por: Stanton-Turcotte, Danielle, et al.
Publicado: (2022)

Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males
por: Kreienkamp, Hans-Jürgen, et al.
Publicado: (2021)

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia
por: Liu, Menghan, et al.
Publicado: (2021)

Common variation at 10p12.31 near MLLT10 influences meningioma risk
por: Dobbins, Sara E, et al.
Publicado: (2011)

KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia
por: Saad, Ashraf Abdullah, et al.
Publicado: (2019)

hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells
por: Feng, Shenglei, et al.
Publicado: (2022)

Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapy
por: Watanabe, Atsushi, et al.
Publicado: (2019)

Duplication of ALK F1245 missense mutation due to acquired uniparental disomy associated with aggressive progression in a patient with relapsed neuroblastoma
por: Kimura, Shunsuke, et al.
Publicado: (2019)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes
por: Wang, Erming, et al.
Publicado: (2007)

HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction
por: Neckles, Carla, et al.
Publicado: (2019)

Two additional males with X‐linked, syndromic mental retardation carry de novo mutations in HNRNPH2
por: Jepsen, Wayne M., et al.
Publicado: (2019)

Interconnected Gene Networks Underpin the Clinical Overlap of HNRNPH1-Related and Rubinstein–Taybi Intellectual Disability Syndromes
por: Larizza, Lidia, et al.
Publicado: (2021)

In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2
por: Velayutham, Sadeeshkumar, et al.
Publicado: (2023)

HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion
por: Lin, Julie Qiaojin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gk4d6r6jcj6c2ne6ep6a2vlv79